Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2026 | Pathology workforce challenges: the need for skilled lab personnel in urothelial cancer diagnostics

Eva Compérat • 14 Mar 2026
EAU 2026
Genitourinary Cancer

Eva Compérat, MD, PhD, Medical University of Vienna, Vienna, Austria, discusses the challenges of finding skilled laboratory personnel to support pathological work, emphasizing that even the best pathologists rely heavily on technicians to perform various techniques, a struggle faced across Europe. This interview took place at the 41st Annual EAU Congress in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Eva Compérat

Molecular testing in prostate cancer: patient selection & urologist-pathologist communication
1:22
Molecular testing in prostate cancer: patient selection & urologist-pathologist communication
Eva Compérat • 14 Mar 2026
Diagnostic challenges in urinary tract diseases: cytology, biopsy, and Lynch syndrome testing
1:01
Diagnostic challenges in urinary tract diseases: cytology, biopsy, and Lynch syndrome testing
Eva Compérat • 14 Mar 2026
Emergence of intravesical therapies in bladder cancer
1:00
Emergence of intravesical therapies in bladder cancer
Eva Compérat • 14 Mar 2026
Challenges in classifying bladder tumors: insights on heterogeneity and precision
5:03
Challenges in classifying bladder tumors: insights on heterogeneity and precision
Eva Compérat • 21 Nov 2023

Related Videos

Enzalutamide outcomes & duration predictors in mHSPC: ARCHES post hoc analyses
3:04
Enzalutamide outcomes & duration predictors in mHSPC: ARCHES post hoc analyses
Andrew Armstrong • 3 Jun 2026
Chemo-IO in neuroendocrine or aggressive variant metastatic prostate cancer
2:24
Chemo-IO in neuroendocrine or aggressive variant metastatic prostate cancer
Andrew Armstrong • 3 Jun 2026
Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer
2:10
Treatment sequencing after EV plus pembrolizumab in metastatic bladder cancer
Tian Zhang • 1 Jun 2026
Highlights in ADCs for bladder cancer at ASCO 2026
1:29
Highlights in ADCs for bladder cancer at ASCO 2026
Tian Zhang • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals